Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U3OY
|
|||
| Former ID |
DIB007730
|
|||
| Drug Name |
Rovelizumab
|
|||
| Synonyms |
LeukArrest; Hu23F2G; Monoclonal antibody (MS), ICOS; 23F2G, ICOS
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Cerebrovascular disease [ICD-11: 8B2Z; ICD-10: I60-I69] | Terminated | [1] | |
| Company |
ICOS Corp
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell adhesion molecule (CADM) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006028) | |||
| REF 2 | Rovelizumab (ICOS Corp). IDrugs. 2000 Apr;3(4):442-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.